-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

906.P1.61 906. Outcomes Research – Myeloid Malignancies: Poster I

Symposia: Outcomes Research—Myeloid Malignancies Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 9, 2023: 5:30 PM-7:30 PM
Halls G-H (San Diego Convention Center)

Andrea Laganson, MS1*, Victoria Klein, MS2*, Deedra Nicolet3, Aadarsh Teli, MS4*, Krzysztof Mrózek, MD, PhD4, Jacob Wareti, MS4*, Michael C Walker, MS4*, Christopher Manring, MBA5*, James L Fisher, PhD6*, Electra D Paskett, PhD7*, Elizabeth Ghias8*, Alice Mims, MD9, Jesse J Plascak, PhD7*, Ann-Kathrin Eisfeld, MD*3 and Jill Buss, BS4

1Clara D. Bloomfield Center for Leukemia Outcomes Research, The Ohio State University Comprehensive Cancer Center, Columbus
2The Ohio State University Comprehensive Cancer Center, Columbus, OH
3Clara D. Bloomfield Center for Leukemia Outcomes Research, The Ohio State University, Columbus, OH
4Clara D. Bloomfield Center for Leukemia Outcomes Research, The Ohio State University Comprehensive Cancer Center, Columbus, OH
5Leukemia Tissue Bank, The Ohio State University Comprehensive Cancer Center, Columbus, OH
6The James Cancer Hospital and Solove Research Institute, Columbus, OH
7Department of Internal Medicine, Division of Cancer Prevention and Control, The Ohio State University Comprehensive Cancer Center, Columbus, OH
8Division of Cancer Prevention and Control/Department of Internal Medicine/College of Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH
9Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, OH

Richard Newcomb, MD1,2*, Hermioni L Amonoo, MD3,4, Ashley M Nelson, PhD3*, Joanna Choe5*, Katherine Holmbeck5*, Anisa Nably5*, Stephanie J. Lee6, Thomas W LeBlanc, MD7 and Areej El-Jawahri, MD5

1Harvard Medical School, Boston
2Massachusetts General Hospital, Winthrop, MA
3Harvard Medical School, Boston, MA
4Dana-Farber Cancer Institute, Boston, MA
5Massachusetts General Hospital, Boston, MA
6Fred Hutchinson Cancer Center, Seattle, WA
7Division of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, NC

Francesco Passamonti1*, Rohan C. Parikh2*, Siddhi Korgaonkar2*, Manoj Chevli3*, Samantha Slaff3*, Julien Rombi4*, Basirat Adeyemi3*, Keith L. Davis2* and Aylin Yucel5*

1Università degli Studi di Milano, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
2RTI Health Solutions, Research Triangle Park, NC
3Bristol Myers Squibb, Princeton, NJ
4RTI Health Solutions, Lyon, France
5Bristol Myers Squibb, Lawrence, NJ

Ahsan Ayaz, MD1*, Syed Arsalan Naqvi, MBBS2*, Saad Farooq, M.D.1*, Kathryn Sickora, D.O.1*, Muhammad Hisham Wazir, M.D.1*, Mahmoud El Hajj, M.D.1*, Tashifa S Lateef, B.S.3*, Adeel Masood, M.D.1*, Saher Amin, M.D.1*, Christopher Rajkumar, M.D.1*, Mehul Patel, M.D.1*, Muhammad Husnain, M.D.4, Irbaz Bin Riaz, MD, MMSc2* and Sajid Ahmad Mir, M.D.1*

1Montefiore St. Luke's Cornwall Hospital, Newburgh, NY
2Mayo Clinic, Phoenix, AZ
3University of Pittsburg, Pittsburgh, PA
4University of Arizona, Tucson, AZ

Miriam A. Osei, MD1,2, Lauren E. Merz, MD, MSc1,2, Kelly S. Chien, MD3, Danielle E. Hammond, MD3, Coleman Lindsley, MD, PhD2,4,5, Marlise R. Luskin, MD1,2,5, Maximilian Stahl, MD2,5,6, Joan How, MD1,2,7, Mohammed Wazir8, Anna E. Marneth, PhD7,9, Shai Shimony, MD5,10*, Ann Mullally, MD2,7, Daniel J. DeAngelo2,4,5, Guillermo Garcia-Manero, MD3, Maureen Okam Achebe, MD, MPH1,2,7, Benjamin L. Ebert, MD, PhD1,2,11,12 and Lachelle D. Weeks, MD, PhD1,2,5,11

1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
2Department of Medicine, Harvard Medical School, Boston, MA
3Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
4Dana-Farber Cancer Institute, Boston, MA
5Center for Adult Leukemia, Dana-Farber Cancer Institute, Boston, MA
6Dana Farber Institute, Boston, MA
7Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Boston, MA
8University of Massachusetts Chan Medical School, Worcester, MA
9Department of Laboratory Medicine, Division Laboratory of Hematology, Radboud University Medical Center, Nijmegen, Netherlands
10Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
11Center for Prevention of Progression, Dana-Farber Cancer Institute, Boston, MA
12Howard Hughes Medical Institute, Boston, MA

Scott F. Huntington, MD, MPH, MSc1, Hsien-Yen Chang, PhD2*, Alex Z. Fu2,3*, Christina Loefgren, MD, PhD4 and Xiaoxiao Lu5*

1Division of Hematology, Yale University, New Haven, CT
2Janssen Scientific Affairs, LLC, Titusville, NJ
3Georgetown University Medical Center, Washington, DC
4Janssen Global Services, LLC, Raritan, NJ
5Real World Value and Evidence, Janssen Scientific Affairs, LLC, Horsham, PA

Alini Maria Orathes Ponte Silva, aliniponte@gmail.com1*, Diego Lopes Paim Miranda, diegolpmiranda@hotmail.com1*, David Pereira Ferreira, dpereiraf@hotmail.com2*, Sheila Freitas, sheilanfreitas@yahoo.com.br1*, Edvan Crusoe, Edvan.Crusoe@ebserh.gov.br3*, Monica Borges Botura Oliveira, monica.oliveira@ebserh.gov.br1*, Lais Teixeira Silva, laist87@hotmail.com1*, Marianna Batista Vieira Lima, marianna.lima@ebserh.gov.br1* and Marco Aurelio Salvino, PhD4

1Hospital Universitário Professor Edgard Santos - Federal University of Bahia (HUPES - UFBA), Salvador, Brazil, Salvador, Brazil
2Federal University of Bahia (HUPES - UFBA), Salvador, Brazil, Salvador, Brazil
3Hospital Universitário Professor Edgar Santos da Universidade Federal da Bahia (HUPES), Salvador, Brazil
4Hospital São Rafael – IDOR / PPGMS-UFBa, Salvador, Brazil, Salvador, Brazil

Daniel J. Zheng, MD1,2, Elsa van der Mei, MPH1,3*, Yimei Li, PhD1,4*, Yuan-Shung V. Huang, MS5*, Catherine Aftandilian, MD6, Kira Bona, MD, MPH7, Emi Caywood, MD8,9, Anderson B. Collier, MD10*, M. Monica Gramatges, MD, PhD11,12, Mallorie M. Heneghan, MD13, Meret Henry, MD14, Craig Lotterman, MD15*, Kelly Maloney, MD16,17*, Tamara P. Miller, MD18,19, Arunkumar Modi, MBBS20, Rajen Mody, MD, MS21*, Elaine Morgan, MD22, Naomi J. Winick, MD23, Jennifer J. Wilkes, MD, MSCE24,25, Victor Wong, MD26*, Haley Newman, MD1, Regina M. Myers, MD1, Caitlin W. Elgarten, MD1, Alix E. Seif, MD, MPH1, Brian T. Fisher, DO, MPH, MSCE3,27*, Richard Aplenc, MD, PhD1,28 and Kelly D. Getz, PhD4,29*

1Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA
2National Clinician Scholars Program, University of Pennsylvania, Philadelphia, PA
3Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
4Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA
5Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, PA
6Department of Pediatrics, Division of Hematology, Oncology and Stem Cell Transplant, Stanford University, Palo Alto, CA
7Division of Pediatric Hematology/Oncology, Boston Children’s Hospital, Boston, MA
8Department of Pediatrics, Thomas Jefferson University, Philadelphia, PA
9Nemours Children's Health, Wilmington, DE
10University of Mississippi, Jackson, MS
11Baylor College of Medicine, Houston, TX
12Pediatric Hematology-Oncology, Texas Children's Hospital, Houston, TX
13Department of Pediatrics, Division of Pediatric Hematology/Oncology, University of Utah, Salt Lake City, UT
14Children's Hospital of Michigan, Detroit, MI
15Ochsner Medical Center for Children, New Orleans, LA
16Department of Pediatrics, Children's Hospital Colorado, Aurora, CO
17University of Colorado School of Medicine, Aurora, CO
18Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA
19Department of Pediatrics, Emory University School of Medicine, Decatur, GA
20Division of Pediatric Hematology Oncology, Arkansas Children's Hospital, Little Rock, AR
21University of Michigan, Ann Arbor, MI
22Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL
23Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX
24Department of Pediatrics, University of Washington School of Medicine, Seattle, WA
25Division of Hematology/Oncology, Seattle Children's Hospital, Seattle, WA
26Division of Pediatric Hematology Oncology, Rady Children's Hospital of San Diego, San Diego, CA
27Division of Infectious Diseases, Children's Hospital of Philadelphia, Philadelphia, PA
28Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
29Division of Oncology, University of Pennsylvania, Philadelphia, PA

Douglas Tremblay, MD1, Grace Van Hyfte2*, John Mascarenhas, MD1* and Jonathan Feld, MD1

1Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
2Icahn School of Medicine At Mount Sinai, New York, NY

Sarah A Wall, MD, MPH1, Allesia Funderburg1*, Nowshin Islam1*, Ying Huang, MS, MA1, Edmund Folefac, MBBS2*, Carolyn Presley, MD2*, Erin Stevens, MD3*, Andrew Artz, MD, MS4 and Ashley E Rosko, MD5

1Division of Hematology, The Ohio State University, Columbus, OH
2Division of Medical Oncology, The Ohio State University, Columbus, OH
3Division of Palliative Medicine, The Ohio State University, Columbus, OH
4City of Hope, Duarte, CA
5The Ohio State University, Columbus, OH

Abdulraheem Yacoub, MD1, Roger M. Lyons, MD2, Evan M. Braunstein, MD, PhD3*, JE Hamer-Maansson, MSPH3*, Tricia Kalafut3* and Ruben A. Mesa, MD4

1University of Kansas Medical Center, Westwood Campus, Westwood, KS
2Texas Oncology and USONCOLOGY Research, San Antonio, TX
3Incyte Corporation, Wilmington, DE
4Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC

Kristin J. Moore, PhD, MPH1*, Nicole M. Engel-Nitz, PhD1*, Peter McMahon2*, Jason Beal2*, Teraneh Z. Jhaveri2*, Mellissa Williamson2*, Katherine Andrade1*, Christina Landis1*, Islam Sadek2 and Cosmina Hogea2*

1Optum, Eden Prairie, MN
2Gilead Sciences, Inc., Foster City, CA

Melissa F Miller, PhD1*, Kimberly Rogers, PhD2*, Stuart L. Goldberg, MD3, Erica E Fortune4*, Victoria G Morris, PhD1*, Tracey Iraca5* and Claire Saxton, MBA1*

1Cancer Support Community, Washington, DC
2Cancer Support Community, Philadelphia, PA
3Division of Leukemia, The John Theurer Cancer Center, Hackensack, NJ
4Research Department, Cancer Support Community, Philadelphia, PA
5MDS Foundation, Yardville, NJ

Kimo Bachiashvili1, Shuko Harada, MD1*, Esprit Ma, MPH2*, Achal Patel, PhD2*, Rongrong Wang, MPH2*, Archibong Yellow-Duke, PharmD2*, Melissa Montez, PharmD2*, Vivek Chopra, PhD2*, Cat N. Bui, PharmD, PhD3* and Pankit Vachhani, MD1*

1O’Neal Comprehensive Cancer Center at the University of Alabama at Birmingham, Birmingham, AL
2Genentech, Inc., South San Francisco, CA
3AbbVie, Inc., Chicago, IL

Mark A Guinter, PhD, MPH1*, Brendan T Kerr, MS1*, Gregory S Calip, PhD, PharmD, MPH1,2, Anita J Kumar, MD, MS1 and Ahmed Sawas, MD1

1Flatiron Health Inc., New York, NY
2Program on Medicines and Public Health, University of Southern California, Los Angeles, CA

Nosakhare Paul Ilerhunmwuwa, MBBS, MSc1, Aditya Keerthi Rayapureddy, MD2*, Ogechi Ogonnaya Agogbuo, MD3*, Janta Ukrani, MD4*, Mustafa Wasifuddin5* and Jen-Chin Wang, MD6

1Department of Medicine, Brookdale University Hospital and Medical Center, Brooklyn, NY
2Department of Medicine, Interfaith Medical Center, Brooklyn, NY
3Texas A&M School of Medicine with Christus Health, Longview, TX
4Mather Hospital/Northwell Health, New York, NY
5Brookdale University Hospital and Medical Center, Brooklyn, NY
6Division of Hematology/Oncology, Brookdale University Hospital and Medical Center, Brooklyn, NY

Ana Cristina Tejada Vasquez1*, Eliezer Gomez, MD2*, Fernando De La Garza, MD3*, Edgar Ulises Coronado Alejandro, MD3*, Carlos De La Cruz-De La Cruz, MD1*, Valeria García-Zárate1*, Anna Cecilia Rodriguez-Zuñiga1*, Alexia Sánchez1*, David Gomez-Almaguer, MD1 and Andres Gomez-De Leon, MD1

1Universidad Autónoma de Nuevo León, Facultad de Medicina y Hospital Universitario Dr. José Eleuterio González, Monterrey, Mexico
2Unidad Médica de Alta Especialidad No. 25, Centro Médico Nacional Noreste, del Instituto Mexicano del Seguro Social, Monterrey, Mexico
3Hospital de Alta Especialidad Christus Muguerza Obispado, Monterrey, Mexico

Rami S. Komrokji, MD1, Nishan Sengupta, PhD2*, Dylan Supina, PhD2*, Shyamala Navada, MD2*, Ravi Potluri, MBA3*, Rohit Tyagi, MPH4*, Tim Werwath, MS3*, Zhuoer Xie, MD, MS1, Eric Padron, MD1 and David A Sallman, MD5

1Moffitt Cancer Center, Tampa, FL
2Geron Corporation, Parsippany, NJ
3Putnam Inizio Advisory, New York, NY
4Putnam Inizio Advisory, Gurugram, India
5H. Lee Moffitt Cancer Center, Tampa, FL

Giovanni Caocci, MD1, Francesca Palandri, MD2*, Giuseppe Gaetano Loscocco3*, Alessia Tieghi, MD4*, Andrea Patriarca, MD5*, Alessandra Iurlo, MD, PhD6*, Elisabetta Abruzzese, MD7, Elena Rossi8*, Thomas Baldi9*, Carmen Fava, MD, PhD10*, Eloise Beggiato11*, Simona Tomasetti12*, Monia Marchetti13*, Daniele Vanni, MD14*, Claudio Fozza, MD15*, Mario Luppi, MD16*, Giorgio La Nasa1*, Paola Fazi, MD9*, Marco Vignetti, MD9*, Alessandro Maria Vannucchi3 and Fabio Efficace, PhD9*

1Department of Medical Sciences and Public Health, University of Cagliari, Businco Hospital, Cagliari, Italy
2Institute of Hematology "L & A Seràgnoli", Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
3CRIMM, Center Research and Innovation of Myeloproliferative Neoplasms, University of Florence, AOU Careggi, Florence, Italy
4Department of Hematology, Azienda Unità Sanitaria Locale (AUSL)-IRCCS, Reggio Emilia, Italy
5Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont and Maggiore Charity Hospital, Novara, Italy
6Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
7Hematology Unit, S. Eugenio Hospital, Rome, Italy
8Institute of Haematology, Catholic University, "A. Gemelli" Academic Hospital, Rome, Italy
9Italian Group for Adult Hematologic Diseases (GIMEMA), Data Center and Health Outcomes Research Unit, Rome, Italy
10Department of Clinical and Biological Sciences, University of Turin, Turin, Italy
11Hematology, AOU Città della Salute e della Scienza di Torino-Presidio Ospedaliero Molinette, Turin, Italy
12Hematology Unit, Department of Oncology and Hematology, Infermi Hospital Rimini, Rimini, Italy
13Hematology Day Service, Oncology SOC, Hospital Cardinal Massaia, Asti, Italy
14Department of Molecular Medicine, University of Pavia, Pavia, Italy
15Department of Medicine, Surgery and Pharmacy, University of Sassari, Sassari, Italy
16Section of Hematology, Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, AOU Modena, Modena, Italy

Thomas Eipe, PharmD1*, Hasmukh Jain, MD, DM2*, Manju Sengar, MD, DM3, Bhausaheb Bagal, MD, DM2*, Lingaraj Nayak, MBBS, MD, DM4* and Alok Shetty, MD, DM2*

1Department of Clinical Pharmacology, Tata Memorial Centre, Mumbai, India
2Department of Medical Oncology, Tata Memorial Centre, Mumbai, India
3Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India
4Department of Medical Oncology, Tata Memorial Centre, MUMBAI, India

*signifies non-member of ASH